Sunshine Biopharma, Inc. (SBFM)

USD 2.75

(0.37%)

Long Term Debt Summary of Sunshine Biopharma, Inc.

  • Sunshine Biopharma, Inc.'s latest annual long term debt in 2023 was 539.03 Thousand USD , down -16.07% from previous year.
  • Sunshine Biopharma, Inc.'s latest quarterly long term debt in 2024 Q2 was 462.9 Thousand USD , down 0.0% from previous quarter.
  • Sunshine Biopharma, Inc. reported annual long term debt of 642.23 Thousand USD in 2022, down -66.2% from previous year.
  • Sunshine Biopharma, Inc. reported annual long term debt of 1.9 Million USD in 2021, up 100.21% from previous year.
  • Sunshine Biopharma, Inc. reported quarterly long term debt of 462.9 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • Sunshine Biopharma, Inc. reported quarterly long term debt of 613.13 Thousand USD for 2023 Q1, down -4.53% from previous quarter.

Annual Long Term Debt Chart of Sunshine Biopharma, Inc. (2023 - 2007)

Historical Annual Long Term Debt of Sunshine Biopharma, Inc. (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 539.03 Thousand USD -16.07%
2022 642.23 Thousand USD -66.2%
2021 1.9 Million USD 100.21%
2020 949 Thousand USD 0.0%
2019 - USD -100.0%
2018 289.84 Thousand USD 263.63%
2017 79.71 Thousand USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%

Peer Long Term Debt Comparison of Sunshine Biopharma, Inc.

Name Long Term Debt Long Term Debt Difference
Theratechnologies Inc. 51.26 Million USD 98.948%
Harrow Health, Inc. 183.17 Million USD 99.706%
Dynavax Technologies Corporation 252.41 Million USD 99.786%
Biofrontera Inc. 804 Thousand USD 32.956%
Cronos Group Inc. 1.55 Million USD 65.424%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -519.58%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.892%
Kala Pharmaceuticals, Inc. 34.19 Million USD 98.423%
RedHill Biopharma Ltd. 455 Thousand USD -18.469%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 95.784%
Radius Health, Inc. 339.66 Million USD 99.841%
Universe Pharmaceuticals INC - USD -Infinity%
DURECT Corporation 2.7 Million USD 80.051%
ProPhase Labs, Inc. 10.25 Million USD 94.745%
Safety Shot Inc 304.9 Thousand USD -76.787%
Phibro Animal Health Corporation 458.28 Million USD 99.882%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -360.206%
Alvotech 1.02 Billion USD 99.948%
Assertio Holdings, Inc. 38.51 Million USD 98.6%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 98.376%
Rockwell Medical, Inc. 8.29 Million USD 93.5%
Procaps Group S.A. 28.41 Million USD 98.103%
Intra-Cellular Therapies, Inc. 13.32 Million USD 95.955%
SCYNEXIS, Inc. 12.15 Million USD 95.567%
Aytu BioPharma, Inc. 10.87 Million USD 95.044%
Viatris Inc. 16.18 Billion USD 99.997%
OptiNose, Inc. 611 Thousand USD 11.778%
SIGA Technologies, Inc. 335.99 Thousand USD -60.431%
Tilray Brands, Inc. 287.93 Million USD 99.813%
PetIQ, Inc. 437.82 Million USD 99.877%
Sunshine Biopharma, Inc. 539.03 Thousand USD 0.0%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.791%
Guardion Health Sciences, Inc. - USD -Infinity%
Alimera Sciences, Inc. 64.48 Million USD 99.164%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.89%
Silver Spike Investment Corp. - USD -Infinity%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -299.022%
Organogenesis Holdings Inc. 60.74 Million USD 99.113%
Journey Medical Corporation 14.62 Million USD 96.314%
Petros Pharmaceuticals, Inc. 6.85 Million USD 92.139%
Alpha Teknova, Inc. 13.25 Million USD 95.932%
Clever Leaves Holdings Inc. 720 Thousand USD 25.134%
Lifecore Biomedical, Inc. 120.51 Million USD 99.553%
PainReform Ltd. 30 Thousand USD -1696.783%
Cosmos Health Inc. 3.03 Million USD 82.241%
Avadel Pharmaceuticals plc 32.75 Million USD 98.355%
TherapeuticsMD, Inc. 6.53 Million USD 91.748%
Embecta Corp. 1.62 Billion USD 99.967%
Regencell Bioscience Holdings Limited - USD -Infinity%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 513.79 Million USD 99.895%
Incannex Healthcare Limited 210 Thousand USD -156.683%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -2297.416%
Shineco, Inc. 10.01 Million USD 94.619%
Procaps Group, S.A. 28.41 Million USD 98.103%
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.826%
Aquestive Therapeutics, Inc. 91.07 Million USD 99.408%
Lantheus Holdings, Inc. 616.12 Million USD 99.913%
Alvotech 1.02 Billion USD 99.948%
Hempacco Co., Inc. 5.93 Million USD 90.912%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 99.041%
Bright Green Corporation 201.78 Thousand USD -167.136%
Esperion Therapeutics, Inc. 501.54 Million USD 99.893%
Kamada Ltd. 7.43 Million USD 92.753%
Indivior PLC 235.66 Million USD 99.771%
Evoke Pharma, Inc. 5 Million USD 89.219%
Flora Growth Corp. 942 Thousand USD 42.778%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -2297.416%
Evolus, Inc. 120.35 Million USD 99.552%
HUTCHMED (China) Limited 48.18 Million USD 98.881%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.909%
Akanda Corp. 2.49 Million USD 78.414%